You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Regulatory Approach for Non-Biological Complex Drugs
- In: SIG Posters
- At: Amsterdam (the Netherlands) (2012)
- Type: Poster
- Poster code: RSC-P-01
- By: BORCHARD, Gerrit (University of Geneva, School of Pharmacy Geneva-Lausanne, Geneva, Switzerland)
- Co-author(s): Flühmann, B. (Vifor Fresenius Medical Care Renal Pharma Ltd., St. Gallen, Switzerland)
Mühlebach, S. (Vifor Fresenius Medical Care Renal Pharma Ltd., St. Gallen, Switzerland) - Abstract:
In the European Union,
..
intended
copies
of originator medicinal products are categorized either as generics or biosimilars and two distinct regulatory pathways have been established for marketing authorization. The major difference between the two product classes refers to the fact that complex biological molecules cannot be fully characterized and The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026